Imaprelimab

CAS No. 2014343-04-3

Imaprelimab( —— )

Catalog No. M37101 CAS No. 2014343-04-3

Imaprelimab (PRX-003) is a humanized IgG1 κ monoclonal antibody targeting melanoma cell adhesion molecule (MCAM), with antitumor activity and applications in studying inflammation, tumors, and psoriasis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 753 In Stock
10MG 1216 In Stock
25MG 1786 In Stock
50MG 2390 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Imaprelimab
  • Note
    Research use only, not for human use.
  • Brief Description
    Imaprelimab (PRX-003) is a humanized IgG1 κ monoclonal antibody targeting melanoma cell adhesion molecule (MCAM), with antitumor activity and applications in studying inflammation, tumors, and psoriasis.
  • Description
    Imaprelimab (PRX-003) is a humanized IgG1κ anti-melanoma cell adhesion molecule (MCAM) monoclonal antibody. Imaprelimab is an antineoplastic agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2014343-04-3
  • Formula Weight
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pelletier JPR, Mukhtar F. Passive Monoclonal and Polyclonal Antibody Therapies. Immunologic Concepts in Transfusion Medicine. 2020:251–348.
molnova catalog
related products